Cameron E Gaskill1,2, Adam Gyedu3,4, Barclay Stewart5,6, Robert Quansah3, Peter Donkor3, Charles Mock5,6,7. 1. Department of Surgery, University of Washington, Seattle, WA, USA. cegaskill@mdanderson.org. 2. Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. cegaskill@mdanderson.org. 3. Department of Surgery, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 4. University Hospital, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 5. Department of Surgery, University of Washington, Seattle, WA, USA. 6. Harborview Injury Prevention and Research Center, Seattle, WA, USA. 7. Department of Global Health, University of Washington, Seattle, WA, USA.
Abstract
BACKGROUND: The Lancet Commission on Global Surgery (LCoGS) recommended an annual surgical rate at which low- and middle-income countries (LMICs) could achieve most of the population-wide benefits of surgery. However, condition-specific guidelines were not proposed. To inform rates of surgery for cancer, we sought to assess the current met and unmet need for oncologic surgery in Ghana. METHODS: Data on all operations performed in Ghana over a one-year period (2014-15) were obtained from representative samples of 48/124 first-level and 12/16 referral hospitals and scaled-up for nationwide estimates. Procedures for cancer were identified by indication. Using modified LCoGS methodology with disease prevalence, Ghana's annual rate of cancer surgery was compared to that of New Zealand to quantify current unmet needs. RESULTS: 232,776 surgical procedures were performed in Ghana; 2,562 procedures (95%UI 1878-3255) were for cancer. Of these, 964 (37%) were surgical biopsies. The annual rate of procedures treating cancer was 2115 surgeries/100,000 cancer cases, or 21% of the New Zealand benchmark. Cervical, breast, and prostate cancer were found to meet 2.1%, 17.2%, and 32.1% of their respective surgical need. CONCLUSIONS: There is a large unmet need for cancer surgery in Ghana. Cancer surgery constitutes under 2% of the total surgeries performed in Ghana, an important proportion of which are used for biopsies. Therapeutic operative rate is deficient across most cancer types, and may lag behind improvements in screening efforts. As cancer prevalence and diagnosis increase in LMICs, cancer-specific surgical capacity must be increased to meet these evolving needs.
BACKGROUND: The Lancet Commission on Global Surgery (LCoGS) recommended an annual surgical rate at which low- and middle-income countries (LMICs) could achieve most of the population-wide benefits of surgery. However, condition-specific guidelines were not proposed. To inform rates of surgery for cancer, we sought to assess the current met and unmet need for oncologic surgery in Ghana. METHODS: Data on all operations performed in Ghana over a one-year period (2014-15) were obtained from representative samples of 48/124 first-level and 12/16 referral hospitals and scaled-up for nationwide estimates. Procedures for cancer were identified by indication. Using modified LCoGS methodology with disease prevalence, Ghana's annual rate of cancer surgery was compared to that of New Zealand to quantify current unmet needs. RESULTS: 232,776 surgical procedures were performed in Ghana; 2,562 procedures (95%UI 1878-3255) were for cancer. Of these, 964 (37%) were surgical biopsies. The annual rate of procedures treating cancer was 2115 surgeries/100,000 cancer cases, or 21% of the New Zealand benchmark. Cervical, breast, and prostate cancer were found to meet 2.1%, 17.2%, and 32.1% of their respective surgical need. CONCLUSIONS: There is a large unmet need for cancer surgery in Ghana. Cancer surgery constitutes under 2% of the total surgeries performed in Ghana, an important proportion of which are used for biopsies. Therapeutic operative rate is deficient across most cancer types, and may lag behind improvements in screening efforts. As cancer prevalence and diagnosis increase in LMICs, cancer-specific surgical capacity must be increased to meet these evolving needs.
Authors: Micaela M Esquivel; George Molina; Tarsicio Uribe-Leitz; Stuart R Lipsitz; John Rose; Stephen Bickler; Atul A Gawande; Alex B Haynes; Thomas G Weiser Journal: World J Surg Date: 2015-09 Impact factor: 3.352
Authors: Adam Gyedu; Barclay Stewart; Cameron Gaskill; Peter Donkor; Robert Quansah; Charles Mock Journal: J Surg Res Date: 2019-11-02 Impact factor: 2.192
Authors: Richard Sullivan; Olusegun Isaac Alatise; Benjamin O Anderson; Riccardo Audisio; Philippe Autier; Ajay Aggarwal; Charles Balch; Murray F Brennan; Anna Dare; Anil D'Cruz; Alexander M M Eggermont; Kenneth Fleming; Serigne Magueye Gueye; Lars Hagander; Cristian A Herrera; Hampus Holmer; André M Ilbawi; Anton Jarnheimer; Jia-Fu Ji; T Peter Kingham; Jonathan Liberman; Andrew J M Leather; John G Meara; Swagoto Mukhopadhyay; Shilpa S Murthy; Sherif Omar; Groesbeck P Parham; C S Pramesh; Robert Riviello; Danielle Rodin; Luiz Santini; Shailesh V Shrikhande; Mark Shrime; Robert Thomas; Audrey T Tsunoda; Cornelis van de Velde; Umberto Veronesi; Dehannathparambil Kottarathil Vijaykumar; David Watters; Shan Wang; Yi-Long Wu; Moez Zeiton; Arnie Purushotham Journal: Lancet Oncol Date: 2015-09 Impact factor: 41.316
Authors: Elissa K Butler; Adam Gyedu; Barclay T Stewart; Robert Quansah; Peter Donkor; Charles N Mock Journal: Eur J Trauma Emerg Surg Date: 2019-11-25 Impact factor: 2.374
Authors: Harald J Hoekstra; Theo Wobbes; Erik Heineman; Samuel Haryono; Teguh Aryandono; Charles M Balch Journal: Ann Surg Oncol Date: 2016-04-01 Impact factor: 5.344